Skip to main content

E83.111 vs T80.90XA

E83.111 (Hemochromatosis due to repeated red blood cell transfusions) compared with T80.90XA (Unspecified complication following infusion and therapeutic injection, initial encounter), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).

Can these codes be reported together?

Yes, when both are documented. T80.90XA carries an Excludes2 note covering E83.111: “transfusion (red blood cell) associated hemochromatosis (E83.111)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

Side by side

E83.111Hemochromatosis due to repeated red blood cell transfusionsT80.90XAUnspecified complication following infusion and therapeutic injection, initial encounter
Billing statusBillableBillable
ClassificationE00-E89 — Endocrine, Nutritional and Metabolic Diseases (E00-E89)S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88)
DefinitionHemochromatosis due to repeated red blood cell transfusions is a billable ICD-10-CM diagnosis code (E83.111).Unspecified complication following infusion and therapeutic injection, initial encounter is a billable ICD-10-CM diagnosis code (T80.90A).
7th characterThe appropriate 7th character is to be added to each code from category T80
Includes
Iron overload due to repeated red blood cell transfusions
Transfusion (red blood cell) associated hemochromatosis
complications following perfusion
Use additional code
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
code(s) to identify the specified condition resulting from the complication
code to identify devices involved and details of circumstances (Y62-Y82)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources